These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20432439)

  • 21. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
    Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
    J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-inflammatory signaling by 24,25-dihydroxyvitamin D3 in HepG2 cells.
    Wehmeier K; Onstead-Haas LM; Wong NC; Mooradian AD; Haas MJ
    J Mol Endocrinol; 2016 Aug; 57(2):87-96. PubMed ID: 27234962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
    Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
    Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.
    Griffin AC; Kern MJ; Kirkwood KL
    Mol Endocrinol; 2012 Oct; 26(10):1682-93. PubMed ID: 22899855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
    Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
    Alroy I; Towers TL; Freedman LP
    Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).
    Buitrago C; Vazquez G; De Boland AR; Boland R
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1150-6. PubMed ID: 11741312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
    DeSmet ML; Fleet JC
    J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
    Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
    J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor.
    Qi X; Tang J; Pramanik R; Schultz RM; Shirasawa S; Sasazuki T; Han J; Chen G
    J Biol Chem; 2004 May; 279(21):22138-44. PubMed ID: 15037631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling.
    Pedigo NG; Zhang H; Bruno ME; Kaetzel CS; Dugan AR; Shanehsaz P; Hennigan RF; Xing Z; Koszewski NJ; Kaetzel DM
    Oncogene; 2005 Apr; 24(16):2654-66. PubMed ID: 15829977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition.
    Qi X; Pramanik R; Wang J; Schultz RM; Maitra RK; Han J; DeLuca HF; Chen G
    J Biol Chem; 2002 Jul; 277(29):25884-92. PubMed ID: 11983707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.